MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

St. Jude Medical Company Profile (NYSE:STJ)

Consensus Ratings for St. Jude Medical (NYSE:STJ) (?)
Ratings Breakdown: 18 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Hold (Score: 2.31)
Consensus Price Target: $73.30 (3.71% downside)

Analysts' Ratings History for St. Jude Medical (NYSE:STJ)
Show:
DateFirmActionRatingPrice TargetActions
5/11/2016BarclaysDowngradeOverweight -> Equal Weight$74.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016SunTrustDowngradeBuy -> Neutral$70.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Credit SuisseDowngradeOutperform -> Neutral$67.00 -> $81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Morgan StanleyDowngradeOverweight -> Equal Weight$67.00 -> $81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016ArgusReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Wells FargoReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016JPMorgan Chase & Co.Reiterated RatingOverweight -> Neutral$66.00 -> $82.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Piper JaffrayDowngradeOverweight -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2016WedbushReiterated RatingOutperform$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/18/2016BTIG ResearchDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2016Bank of AmericaReiterated RatingBuy$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016OppenheimerBoost Price TargetMarket Perform$57.00 -> $67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Jefferies GroupBoost Price TargetHold$55.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Cowen and CompanyUpgradeMarket Perform -> Outperform$66.00 -> $73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016BMO Capital MarketsBoost Price TargetOutperform$66.00 -> $73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016NomuraInitiated CoverageBuy$64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/25/2016RBC CapitalLower Price TargetSector Perform$66.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2016Deutsche BankLower Price TargetHold$65.00 -> $64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/4/2016Sterne Agee CRTLower Price TargetBuy$81.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/1/2015Evercore ISIReiterated RatingHold$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015S&P Equity ResearchReiterated RatingBuy$92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015CRT CapitalLower Price TargetBuy$80.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/17/2014Citigroup Inc.Reiterated RatingSell$53.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for St. Jude Medical (NYSE:STJ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/20/2016        
4/20/2016Q116$0.88$0.90$1.43 billion$1.45 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2016Q415$1.01$1.02$1.48 billion$1.45 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2015Q315$0.97$0.97$1.35 billion$1.34 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2015Q215$1.00$1.03$1.39 billion$1.41 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2015Q115$0.91$0.93$1.35 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q414$1.03$1.03$1.44 billion$1.44 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/15/2014Q314$0.96$0.97$1.39 billion$1.38 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/16/2014Q214$1.00$1.02$1.44 billion$1.45 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/16/2014Q114$0.95$0.96$1.36 million$1.36 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/22/2014Q413$0.97$0.99$1.38 billion$1.42 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2013Q313$0.89$0.90$1.32 billion$1.34 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2013Q2 2013$0.94$0.96$1.36 billion$1.40 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2013Q1 2013$0.91$0.92$1.36 billion$1.34 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/23/2013Q4 2012$0.87$0.92$1.37 billion$1.37 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2012$0.81$0.83ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2012$0.87$0.86ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2012$0.83$0.86ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2012$0.84$0.86ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/19/2011$0.76$0.78ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/20/2011$0.84$0.85ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2011$0.78$0.80ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2011$0.74$0.75ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for St. Jude Medical (NYSE:STJ)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.88$1.04$0.92
Q2 20167$0.99$1.13$1.05
Q3 20165$0.99$1.03$1.01
Q4 20168$1.06$1.11$1.09
Q1 20177$0.98$1.16$1.03
Q2 20177$1.08$1.25$1.15
Q3 20175$1.09$1.16$1.12
Q4 20176$1.14$1.24$1.20
(Data provided by Zacks Investment Research)
Current Dividend Information for St. Jude Medical (NYSE:STJ)
Annual Dividend:$1.24
Dividend Yield:1.63%
Payout Ratio:30.54%
Dividend Growth:8.20% (3 Year Average)

Dividend History for St. Jude Medical (NYSE:STJ)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/4/2016quarterly$0.311.64%6/28/20166/30/20167/29/2016Tweet This Announcement  Share This Announcement on StockTwits
2/19/2016quarterly$0.312.3%3/29/20163/31/20164/29/2016Tweet This Announcement  Share This Announcement on StockTwits
12/7/2015quarterly$0.291.9%12/29/201512/31/20151/29/2016Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015quarterly$0.291.58%9/28/20159/30/201510/30/2015Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015quarterly$0.291.63%6/26/20156/30/20157/31/2015Tweet This Announcement  Share This Announcement on StockTwits
2/20/2015quarterly$0.291.69%3/27/20153/31/20154/30/2015Tweet This Announcement  Share This Announcement on StockTwits
10/21/2014quarterly$0.271.81%12/29/201412/31/20141/30/2015Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014quarterly$0.271.62%9/26/20149/30/201410/31/2014Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014quarterly$0.271.71%6/26/20146/30/20147/31/2014Tweet This Announcement  Share This Announcement on StockTwits
2/24/2014quarterly$0.271.6%3/27/20143/31/20144/30/2014Tweet This Announcement  Share This Announcement on StockTwits
12/9/2013quarterly$0.251.68%12/27/201312/31/20131/31/2014Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013quarterly$0.251.91%9/26/20139/30/201310/31/2013Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013quarterly$0.252.46%6/26/20136/28/20137/31/2013Tweet This Announcement  Share This Announcement on StockTwits
2/25/2013quarterly$0.252.45%3/26/20133/29/20134/30/2013Tweet This Announcement  Share This Announcement on StockTwits
12/11/2012quarterly$0.232.59%12/27/201212/31/20121/31/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for St. Jude Medical (NYSE:STJ)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/5/2016Jeff FechoVPSell10,408$51.71$538,197.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2015Donald ZurbayCFOSell3,106$60.96$189,341.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2015Jeff DallagerVPSell501$60.94$30,530.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2015John C HeinmillerEVPSell8,009$61.16$489,830.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2015Daniel J. StarksCEOSell120,000$62.36$7,483,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2015Daniel J StarksCEOSell100,000$72.46$7,246,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Mark W MurphyVPSell5,882$72.45$426,150.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015Jason ZellersVPSell3,566$74.13$264,347.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015Joel BeckerInsiderSell17,870$73.87$1,320,056.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015John C HeinmillerEVPSell160,000$73.69$11,790,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015Lisa AndradeCMOSell5,000$73.87$369,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015Stuart EssigDirectorSell7,750$73.85$572,337.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2015I Paul BaeVPSell34,000$73.00$2,482,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2015Lisa AndradeCMOSell5,000$70.55$352,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Michael A RoccaDirectorSell3,875$65.57$254,083.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Michael T RousseauCOOSell7,207$67.31$485,103.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Denis M GestinInsiderSell148,500$67.13$9,968,805.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Scott ThomeVPSell6,666$67.94$452,888.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Mark W MurphyVPSell859$66.92$57,484.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Richard R DevenutiDirectorSell7,750$66.43$514,832.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014John C HeinmillerEVPSell6,853$64.60$442,703.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014Jeff FechoVPSell500$60.55$30,275.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2014Jason ZellersVPSell33,999$60.04$2,041,299.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/22/2014Daniel J StarksCEOSell100,000$60.04$6,004,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Mark CarlsonVPSell1,198$66.40$79,547.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2014Daniel J StarksCEOSell90,000$66.25$5,962,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2014Mark W MurphyVPSell2,000$66.43$132,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2014Denis M GestinInsiderSell99,000$66.76$6,609,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2014Rachel EllingsonVPSell2,630$66.72$175,473.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2014Scott ThomeVPSell5,997$67.06$402,158.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2014Michael RoccaDirectorSell5,600$60.36$338,016.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2014Scott ThomeVPSell7,500$59.57$446,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014Michael RousseauCOOSell4,644$59.76$277,525.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2014Jeff FechoVPSell10,408$61.28$637,802.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2014Joel BeckerInsiderSell14,164$61.58$872,219.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014Mark MurphyVPSell9,480$63.14$598,567.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2013Joel BeckerInsiderSell37,916$59.54$2,257,518.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2013John HeinmillerEVPSell4,144$59.49$246,526.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2013Frank CallaghanInsiderSell73,826$59.28$4,376,405.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013Daniel StarksCEOSell108,000$59.41$6,416,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2013Daniel StarksCEOSell108,000$57.33$6,191,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2013Michael T RousseauInsiderSell50,000$57.81$2,890,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Kathy ChesterVPSell9,375$58.12$544,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Michael T RousseauInsiderSell50,000$57.76$2,888,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Donald ZurbayCFOSell40,000$57.31$2,292,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Mark W MurphyVPSell5,024$57.51$288,930.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/25/2013Jason ZellersVPSell14,917$57.15$852,506.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Joel BeckerInsiderSell9,613$56.48$542,942.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2013John C HeinmillerEVPSell150,000$56.48$8,472,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2013Kathy ChesterVPSell20,000$56.50$1,130,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/22/2013Angela D CraigVPSell24,402$56.59$1,380,909.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Frank J CallaghanInsiderSell133,096$56.26$7,487,980.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Mark W MurphyVPSell3,930$56.26$221,101.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/18/2013Jason ZellersVPSell10,916$56.56$617,408.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/18/2013Michael T RousseauInsiderSell61,000$56.65$3,455,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/18/2013Wendy L YarnoDirectorSell22,150$56.50$1,251,475.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/4/2013Denis GestinInsiderSell137,000$55.25$7,569,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/4/2013Donald ZurbayCFOSell12,000$55.55$666,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013Mark MurphyVPSell4,200$53.50$224,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2013Angela CraigVPSell13,600$54.00$734,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2013Frank CallaghanInsiderSell11,000$54.00$594,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013Jason ZellersVPSell10,359$52.22$540,946.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013Stuart EssigDirectorSell5,600$52.19$292,264.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Kathy ChesterVPSell16,250$52.00$845,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2013Jason ZellersVPSell7,341$51.91$381,071.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Donald ZurbayCFOSell50,000$51.28$2,564,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Jeff FechoVPSell13,848$50.82$703,755.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Joel BeckerInsiderSell11,700$50.50$590,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2013Richard R DevenutiDirectorSell5,270$40.64$214,172.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2013Denis M GestinInsiderSell90,000$41.32$3,718,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2013Thomas R NorthenscoldVPSell22,000$41.40$910,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/25/2012John W BrownDirectorBuy25,000$38.65$966,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for St. Jude Medical (NYSE:STJ)
DateHeadline
06/27/16 06:29 PMStrong Sell Calls Recommendations For St. Jude Medical, Inc. (NYSE:STJ) At 0 - Investor Newswire
06/27/16 10:12 AMWere Analysts Bullish St. Jude Medical, Inc. (NYSE:STJ) This Week? - Engelwood Daily
06/27/16 08:31 AMMedtronic Rounds Out Heart-Failure Offerings With HeartWare Buy -
06/26/16 10:10 AMStock Performance Focus on: St. Jude Medical Inc. (NYSE:STJ) - Press Telegraph
06/26/16 10:10 AMSt. Jude Medical Expands Its Heart Failure Portfolio With SyncAV CRT Technology, Providing Physicians Another ... - Med Device Online (press release)
06/24/16 06:39 PMSt. Jude Medical Inc. versus Stryker Corporation Head to Head Compare - CML News
06/24/16 06:39 PMWatchful Active Movers- AstraZeneca PLC (NYSE:AZN), St. Jude Medical Inc. (NYSE:STJ), KBR, Inc. (NYSE:KBR) - Seneca Globe
06/24/16 09:09 AMSt. Jude Medical scores CE mark for its SyncAV CRT software
06/23/16 07:18 PMSt. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another ... - Business Wire (press release)
06/23/16 09:13 AMSt. Jude Medical expands its heart failure portfolio by launching SyncAV CRT technology
06/23/16 09:13 AMSt. Jude Medical Expands Heart Failure Portfolio With SyncAV CRT Tech
06/23/16 07:55 AMBRIEF-St. Jude Medical says announces CE Mark approval and launch of SyncAV CRT software - * Announced ce mark approval and launch of syncav crt software Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
06/23/16 07:19 AMSt. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies - [at noodls] - http://www.businesswire.com/news/home/20160623005366/en/ Quadra Assura MP CRT-D. Courtesy of St. Jude Medical. ... This is an abstract of the original noodl. To continue reading this document, click here ...
06/23/16 07:09 AM8:09 am St. Jude Medical announces CE Mark approvals for its SyncAV CRT software and its Quadra Assura MP CRT-Defibrillator with full-body magnetic resonance labeling -
06/22/16 07:26 AMWalgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes -
06/20/16 08:05 AMSt Jude Medical : HeartMate 3 Left Ventricular Assist System Wins CARDIOSTIM-EHRA EUROPACE Innovation Award
06/20/16 07:00 AMSt. Jude Medical HeartMate 3 Left Ventricular Assist System Wins CARDIOSTIM-EHRA EUROPACE Innovation Award - [Business Wire] - St. Jude Medical, Inc. , a global medical device company, today announced the company has received an Innovation Award for its HeartMate 3™ Left Ventricular Assist System at the 2016 CARDIOSTIM EHRA EUROPACE International Congress of electrophysiology and cardiac technology.
06/18/16 10:31 AMRecently Issued Stock Ratings For St. Jude Medical, Inc. (NYSE:STJ) - Fiscal Standard
06/16/16 06:50 PMSt Jude Medical : $28,490 Federal Contract Awarded to St. Jude Medical
06/16/16 06:50 PMSt. Jude launches Infinity deep brain stim system in the EU
06/16/16 06:50 PMSt. Jude Medical launches new deep brain stimulation system and directional lead in Europe
06/16/16 06:50 PMSt. Jude Medical Launches Deep Brain Stimulation System In Europe - Quick Facts
06/16/16 06:50 PMSt. Jude Medical launches new DBS system in Europe
06/16/16 11:00 AMStocks Analysts Ranking Summary: Merck & Company, Inc. (NYSE:MRK) , St. Jude Medical, Inc. (NYSE:STJ) - Street Updates
06/16/16 11:00 AMHC Stocks Growth: Intrexon Corp (NYSE:XON), St. Jude Medical, Inc. (NYSE:STJ) - share market updates (press release)
06/16/16 11:00 AMSt. Jude Medical Broadens Treatment Options for Patients Suffering Movement Disorders with the European Launch of ... - Business Wire (press release)
06/16/16 07:39 AMSt. Jude Medical Broadens Treatment Options for Patients Suffering Movement Disorders with the European Launch of New Deep Brain Stimulation System and Directional Lead - [at noodls] - http://www.businesswire.com/news/home/20160616005419/en/ The St. Jude Medical Infinity DBS system is the only upgradeable DBS system available to patients battling movement disorders. (Photo: St. Jude ...
06/15/16 09:58 AMRevenue Estimates Analysis: St. Jude Medical Inc. (NYSE:STJ) - News Oracle
06/14/16 09:58 AMTrend Of Rating Given To St. Jude Medical, Inc. (NYSE:STJ) - Investor Newswire
06/14/16 09:58 AMHC Stocks Reports Analysis: Rock Creek Pharmaceuticals Inc (RCPI), St. Jude Medical, Inc. (STJ) - share market updates (press release)
06/14/16 09:58 AMAnalyst Overview on These 2 Stocks: St. Jude Medical Inc. (NYSE:STJ), The Allstate Corporation (NYSE:ALL) - Beacon Chronicle
06/14/16 09:58 AMSt Jude Medical Inc (NYSE:STJ) near 52-week high, short interest surging - Street Report
06/10/16 06:58 PMStocks Earnings Review: St. Jude Medical Inc. (NYSE:STJ), Electronic Arts Inc. (NASDAQ:EA) - Beacon Chronicle
06/09/16 07:06 PMAnalyst Earnings Report: St. Jude Medical Inc. (NYSE:STJ), Statoil ASA (NYSE:STO) - Beacon Chronicle
06/09/16 08:21 AMTakeover Talk A Help To Wide-Moat ETFs -
06/08/16 09:44 AMEarnings Report of the Stocks: St. Jude Medical Inc. (NYSE:STJ), Basic Energy Services, Inc. (NYSE:BAS) - Beacon Chronicle
06/07/16 06:54 PMStock under Analysts' radar: St. Jude Medical Inc. (NYSE:STJ) - News Oracle
06/07/16 06:54 PMST. JUDE MEDICAL INC. (NYSE:STJ) Financial Condition Compared to S&P 500 - CML News
06/07/16 03:58 PMST JUDE MEDICAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/07/16 09:25 AMAbbVie Inc (NYSE:ABBV) & St. Jude Medical, Inc. (NYSE:STJ) Healthcare Stock's Buzzers - Wall Street 24
06/07/16 09:25 AMStocks with Buy Signals: St. Jude Medical Inc. (NYSE:STJ), Teva Pharmaceutical Industries Limited (NYSE:TEVA) - Beacon Chronicle
06/06/16 06:45 PMAnalyst Opinions on: St. Jude Medical Inc. (NYSE:STJ), Occidental Petroleum Corporation (NYSE:OXY) - Beacon Chronicle
06/06/16 10:39 AMSt. Jude Medical CardioMEMS HF System is Now Guideline Directed Therapy for Heart Failure Patients in Europe - Business Wire (press release)
06/06/16 10:39 AMAnalyst Recommendations Review: St. Jude Medical Inc. (NYSE:STJ) - News Oracle
06/06/16 10:39 AMHC Stocks Movements Activity: AstraZeneca plc (ADR) (NYSE:AZN), St. Jude Medical, Inc. (NYSE:STJ) - share market updates (press release)
06/06/16 07:08 AMSt. Jude Medical CardioMEMS HF System is Now Guideline Directed Therapy for Heart Failure Patients in Europe - [at noodls] - http://www.businesswire.com/news/home/20160606005438/en/ The CardioMEMS HF System uses a miniaturized, wireless monitoring sensor that is implanted in the pulmonary artery. (Photo: Business Wire) Robust ...
06/05/16 09:18 AMPerformance Review for St. Jude Medical Inc. (NYSE:STJ) - HNN
06/03/16 09:36 AMAnalyst Recommendations on These Hot Stocks: Cabela's Incorporated (NYSE:CAB), St. Jude Medical Inc. (NYSE:STJ) - Beacon Chronicle
06/03/16 09:36 AMEye on Earnings: St. Jude Medical, Inc. (NYSE:STJ) - Investor Newswire
06/02/16 07:05 PMStrong Sell Calls Count For St. Jude Medical, Inc. (NYSE:STJ) At 0 - Investor Newswire - Strong Sell Calls Count For St. Jude Medical, Inc. (NYSE:STJ) At 0Investor NewswireThe Sell calls on St. Jude Medical, Inc. (NYSE:STJ) were 0. Two months earlier 4 were the Strong Buy calls whereas Strong Sell calls were 0. During this period, the hold calls were 18. The buy recommendations were 0 and sell calls count was 0. Analyst ...and more »
About St. Jude Medical

St. Jude Medical logoSt. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: STJ
  • CUSIP: 79084910
Key Metrics:
  • Previous Close: $76.12
  • 50 Day Moving Average: $76.98
  • 200 Day Moving Average: $62.48
  • P/E Ratio: 30.58
  • P/E Growth: 1.79
  • Market Cap: $21.64B
  • Current Quarter EPS Consensus Estimate: $4.06 EPS
Additional Links:
St. Jude Medical (NYSE:STJ) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha